Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India
The net worth of the market share of veterinary vaccines is predicted to grow from US$ 11.3 Billion in 2023 to over US$ 20.82 billion by 2033. This is expected to further drive the market share of veterinary vaccines and register a CAGR of 6.2% between 2023 and 2033.
By controlling and preventing serious epidemic diseases, veterinary vaccines are often crucial to animal health protection. Throughout the forecast years, the veterinary vaccines market is expected to grow due primarily to the high adoption of pet animals across the globe.
This is due to increased expenditure on pet care, and increased adoption of efficient immunizations. For instance, Americans spent US$ 69.51 billion in 2017 on their pets, according to the Annual Industry-wide Spending Figures at the Global Pet Expo in Orlando, Florida.
In recent years, zoonotic diseases have become increasingly common and have led to a rise in interest in companion animal vaccines. A key factor contributing to advancement in this field is the emergence of new zoonotic diseases, government investments, and pet lovers' increased expenditures on animal health.
As a result of the development of novel vaccines that can target dangerous zoonotic diseases such as E. coli O157:H7. E. coli O157:H7 is a foodborne disease that can cause HUS and kidney failure. Veterinary vaccines have made a significant impact on human health, welfare, and production in recent years.
As a result of novel research in the field, the market for veterinary vaccines is expected to grow. This is because more vaccines are developed, adjuvants are developed, and pharmaceutical residuals are reduced in the human food chain.
In addition, the persistent economic slowdown, rising storage costs, and an increase in vegetarianism are significant factors limiting the market. With reduced costs, more investments in animal health, and skilled professionals, this market could have lucrative growth prospects.
Attributes | Details |
---|---|
Veterinary Vaccines Market Value (2023) | US$ 11.3 Billion |
Veterinary Vaccines Market Expected Value (2033) | US$ 20.82 Billion |
Veterinary Vaccines Market Projected CAGR (2023 to 2033) | 6.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing Penetration of Animal Immunization Driving Market Expansion
The global veterinary vaccines market is forecast to grow a robust CAGR of 6.2% between 2023 and 2033 in comparison to 6.5% registered from 2017 to 2022. The rising prevalence of zoonotic diseases, increasing demand for animal products, growing trend of pet adoption across the world, and exponential growth of the animal healthcare products market are some of the key factors driving the global veterinary vaccines market.
Similarly, the rapid expansion of the veterinary respiratory disease treatment market and the veterinary pain management drugs market due to increasing spending by pet owners on improving the health of their pets will create sales prospects for veterinary vaccines throughout the forecast period.
Veterinary vaccines are gaining popularity for their ability to protect animal health as well as public health as they effectively mimic naturally acquired immunity. Veterinary vaccine sales are especially high across developed nations due to increasing pet ownership. These vaccines play a crucial role in assuring longevity and good health in animals.
Attribute | Details |
---|---|
Historical CAGR (2016 to 2022) | 6.5% |
Historical Market Value | US$ 10.7 Billion |
Forecast CAGR | 6.2% |
Veterinary Vaccines Market:
Differentiating Aspects | Veterinary Vaccines Market |
---|---|
CAGR (2023 to 2033) | 6.2% |
Market Valuation in 2023 | US$ 11.3 Billion |
Projected Market Value in 2033 | US$ 20.82 Billion |
Growth Factors | Awareness and innovation of new inoculation products. |
Opportunities | Rise in revenue due to increasing purchase of veterinary vaccines online |
Key Trends | Technological advancement in animal immunization |
Veterinary Therapeutics Market:
Differentiating Aspects | Veterinary Therapeutics Market |
---|---|
CAGR (2023 to 2033) | 5.8% |
Market Valuation in 2023 | US$ 49.09 Billion |
Projected Market Value in 2033 | US$ 86.27 Billion |
Growth Factors | Increasing demand for meat and other animal products. |
Opportunities | A rise in the use of drugs in livestock animals and the approval of new products. |
Key Trends | Increasing trend of preventive therapeutics designed to prevent the occurrence of a disease. |
Animal Health Market:
Differentiating Aspects | Animal Health Market |
---|---|
CAGR (2023 to 2033) | 6.3% |
Market Valuation in 2023 | US$ 56.33 Billion |
Projected Market Value in 2033 | US$ 103.76 Billion |
Growth Factors | An increase in zoonotic diseases is expected to drive the market. |
Opportunities | The potential for lucrative growth opportunities in veterinary medicine can be enhanced by increasing Research and Development (R&D) activities. |
Key Trends | People are adopting pets for companionship at an increasing rate. |
The prevalence of a variety of animal diseases worldwide not only affects animals' health but is also dangerous for humans. For this reason, various governments are adopting mass vaccination programs for animals to stop disease transmission from animals to humans. This is expected to create significant demand for vaccines for national stockpiles.
Increasing initiatives and investments by governments around the world to tackle animal disease burden and ensure food security is anticipated to push the demand for veterinary vaccines in the future.
Currently, the veterinary healthcare industry is experiencing immense demand for protozoan parasitic vaccines and the trend is likely to escalate during the forecast period. Leading players have shifted their preference towards the production of third-generation DNA veterinary vaccines for protection against protozoan parasites due to their effective nature.
Consequently, the booming animal vaccines market worldwide will continue to create a conducive environment for veterinary vaccine suppliers during the forecast period.
In addition, technological advancements and the subsequent launch of animal products are critical factors. Since animal immunizations were first introduced to the general public, they have undergone major R&D developments. In the field of animal and human health, vaccinations utilizing conventionally attenuated and inactivated pathogens have made significant and critical contributions.
Nevertheless, inactivated vaccines often can only partially mimic the drawbacks of traditional animal immunization, such as the complex immunogenicity of certain bacterial pathogens. Because of these factors, recombinant vaccines have been developed, which have many advantages, including not exposing the vaccine recipient to the pathogen during vaccination.
A further driving force behind the widespread adoption of animal inoculation products is the prevention of animal diseases that can be transmitted to humans and cause epidemics.
Lack of Animal Vaccination Awareness Among Smallholder Farmers
Despite its optimistic stance, the global veterinary vaccines market is facing various challenges that are likely to slow down its growth during the forecast period. Some of these factors are the lack of awareness and accessibility for smaller farmers, low healthcare awareness in some regions, and the possibility of harmful outcomes of animal vaccinations. Similarly, the high
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Attenuated Live Vaccines Improving Public Health by Controlling Contagious Diseases
Attenuated live vaccines remain the most preferred product in the global veterinary vaccines market and are expected to account for 24.3% of the global market share in 2023. These vaccines are high in demand due to their strong, effective, and long-lasting nature.
Increasing Livestock Animal Immunization Creating Strong Demand for Veterinary Vaccines
In terms of species, livestock animals accounted for a major revenue share in the market due to the growing need for livestock animal immunization to assure the safety of food and dairy products.
Livestock animals are essential sources of primary and secondary food items that humans utilize in their daily routine’s life. Thus, ensuring proper health of these has become a top priority, thereby prompting farmers to use healthcare products like veterinary vaccines.
Similarly, the rapid growth of the animal vaccines market across developed and developing regions will further aid the growth in this segment.
Huge Demand for Pet Vaccines Across the Continent
North America continues to shape revenue generation in the global veterinary vaccines market due to an uptick in the usage of efficacious pet vaccines in tandem with tech-advanced vaccine delivery equipment, a rise in pet adoption rates, and rapid expansion of the animal vaccines market.
Furthermore, increasing awareness among consumers regarding the prevailing veterinary vaccine market trends is likely to favor the market in North America during the forecast period.
Advancements in Biotechnology and Veterinary Science to Drive Market Expansion
The USA will continue to be a prominent market for veterinary vaccines due to the increasing frequency of drug approvals, advances in veterinary science, rise in pet adoption rate, and the emergence of new veterinary vaccine market trends.
Similarly, increasing focus on innovation to avoid zoonotic diseases coupled with advancements in biotechnology and rapid growth of the animal healthcare market is expected to create a favorable platform for the development of veterinary vaccines in the USA
A Growing Number of Zoonotic Diseases are Driving Market Expansion
Germany held significant revenue across the forecast years with a stable growth rate. As a result of the increasing adoption of pet animals, a growing prevalence of zoonotic diseases, a growing number of veterinary clinics, and improved healthcare infrastructure in European countries, Germany is expected to hold the first leading revenue position in Europe.
Growing Innovation of Veterinary Medical Devices to Fuel Growth
China is also emerging as an opportunistic market for veterinary vaccines, underpinned by collaborative initiatives of governments and private firms to promote better animal healthcare with advanced veterinary medical devices.
Livestock and companion animal owners across the country are showing a keen interest in following regular vaccination schedules, which is expected to push the veterinary vaccine sales in the country during the forecast period.
In the past few years, veterinary vaccination has witnessed several technological advancements. Recombinant DNA technology has been used for several immunization products, including DNA vaccines.
As a result of novel technology, the stability of the drug has also been improved, and it is easier to administer the drug. Nucleic acid is an immunization technology that falls between the life and killed approaches.
Several key players are involved in the continuous advancement of product development tools to develop innovative and efficient veterinary vaccines based on DNA cloning into a delivery plasmid or direct injection of messenger RNA.
Some of the prominent players in the veterinary vaccines market are as follows:
Recent Development: Large Scale Investment in R&D Activities for the Development of New Vaccines
Leading veterinary vaccine manufacturers are continuously investing in research and development activities for introducing effective vaccines. Besides this, they have adopted various market strategies such as joint ventures, collaborations, partnership agreements, sales agreements, and capacity expansion to expand their global footprint. For instance,
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2023 |
Market Analysis | US$ million for Value and MT for Volume |
Key Regions Covered |
|
Key Countries Covered | The USA, Canada, Brazil, Mexico, Chile, Peru, Germany, The United Kingdom, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Turkey |
Key Segments Covered |
|
Key Companies Profiled |
|
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
1. Executive Summary | Veterinary Vaccines Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Species Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ million) Analysis By Species Type, 2017 to 2022 5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Species Type, 2023 to 2033 5.3.1. Companion Animals 5.3.1.1. Canine 5.3.1.2. Avian 5.3.1.3. Feline 5.3.2. Livestock Animals 5.3.2.1. Aquatic 5.3.2.2. Bovine 5.3.2.3. Porcine 5.3.2.4. Ovine/Caprine 5.3.2.5. Poultry 5.3.3. Equine 5.4. Y-o-Y Growth Trend Analysis By Species Type, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Species Type, 2023 to 2033 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ million) Analysis By Product, 2017 to 2022 6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product, 2023 to 2033 6.3.1. Attenuated Live Vaccines 6.3.2. Conjugate Vaccines 6.3.3. Inactivated Vaccines 6.3.4. Subunit Vaccines 6.3.5. Toxoid Vaccines 6.3.6. DNA Vaccines 6.3.7. Recombinant Vaccines 6.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Disease 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ million) Analysis By Disease, 2017 to 2022 7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Disease, 2023 to 2033 7.3.1. Anaplasmosis 7.3.2. Canine Parvovirus 7.3.3. Foot & Mouth Disease 7.3.4. New Castle Disease 7.3.5. Distemper Disease 7.3.6. Influenza 7.3.7. Porcine Reproductive & Respiratory Syndrome 7.3.8. Others 7.4. Y-o-Y Growth Trend Analysis By Disease, 2017 to 2022 7.5. Absolute $ Opportunity Analysis By Disease, 2023 to 2033 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ million) Analysis By Distribution Channel, 2017 to 2022 8.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Distribution Channel, 2023 to 2033 8.3.1. Veterinary Clinics 8.3.2. Veterinary Hospitals 8.3.3. Veterinary Research Institutes 8.3.4. Retail Pharmacies 8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2022 8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022 9.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. Asia Pacific excluding Japan (APEJ) 9.3.6. Japan 9.3.7. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. The USA 10.2.1.2. Canada 10.2.2. By Species Type 10.2.3. By Product 10.2.4. By Disease 10.2.5. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Species Type 10.3.3. By Product 10.3.4. By Disease 10.3.5. By Distribution Channel 10.4. Key Takeaways 11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Species Type 11.2.3. By Product 11.2.4. By Disease 11.2.5. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Species Type 11.3.3. By Product 11.3.4. By Disease 11.3.5. By Distribution Channel 11.4. Key Takeaways 12. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. The United Kingdom 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Nordic countries 12.2.1.7. BENELUX 12.2.1.8. Rest Of Western Europe 12.2.2. By Species Type 12.2.3. By Product 12.2.4. By Disease 12.2.5. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Species Type 12.3.3. By Product 12.3.4. By Disease 12.3.5. By Distribution Channel 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Russia 13.2.1.2. Poland 13.2.1.3. Rest Of Eastern Europe 13.2.2. By Species Type 13.2.3. By Product 13.2.4. By Disease 13.2.5. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Species Type 13.3.3. By Product 13.3.4. By Disease 13.3.5. By Distribution Channel 13.4. Key Takeaways 14. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. India 14.2.1.3. ASEAN 14.2.1.4. Australia & New Zealand 14.2.2. By Species Type 14.2.3. By Product 14.2.4. By Disease 14.2.5. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Species Type 14.3.3. By Product 14.3.4. By Disease 14.3.5. By Distribution Channel 14.4. Key Takeaways 15. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.2. By Species Type 15.2.3. By Product 15.2.4. By Disease 15.2.5. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Species Type 15.3.3. By Product 15.3.4. By Disease 15.3.5. By Distribution Channel 15.4. Key Takeaways 16. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 16.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest Of MEA 16.2.2. By Species Type 16.2.3. By Product 16.2.4. By Disease 16.2.5. By Distribution Channel 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Species Type 16.3.3. By Product 16.3.4. By Disease 16.3.5. By Distribution Channel 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. The USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Species Type 17.1.2.2. By Product 17.1.2.3. By Disease 17.1.2.4. By Distribution Channel 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Species Type 17.2.2.2. By Product 17.2.2.3. By Disease 17.2.2.4. By Distribution Channel 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Species Type 17.3.2.2. By Product 17.3.2.3. By Disease 17.3.2.4. By Distribution Channel 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Species Type 17.4.2.2. By Product 17.4.2.3. By Disease 17.4.2.4. By Distribution Channel 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Species Type 17.5.2.2. By Product 17.5.2.3. By Disease 17.5.2.4. By Distribution Channel 17.6. The United Kingdom 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Species Type 17.6.2.2. By Product 17.6.2.3. By Disease 17.6.2.4. By Distribution Channel 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Species Type 17.7.2.2. By Product 17.7.2.3. By Disease 17.7.2.4. By Distribution Channel 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Species Type 17.8.2.2. By Product 17.8.2.3. By Disease 17.8.2.4. By Distribution Channel 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Species Type 17.9.2.2. By Product 17.9.2.3. By Disease 17.9.2.4. By Distribution Channel 17.10. Nordic countries 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Species Type 17.10.2.2. By Product 17.10.2.3. By Disease 17.10.2.4. By Distribution Channel 17.11. BENELUX 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Species Type 17.11.2.2. By Product 17.11.2.3. By Disease 17.11.2.4. By Distribution Channel 17.12. Russia 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Species Type 17.12.2.2. By Product 17.12.2.3. By Disease 17.12.2.4. By Distribution Channel 17.13. Poland 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Species Type 17.13.2.2. By Product 17.13.2.3. By Disease 17.13.2.4. By Distribution Channel 17.14. China 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Species Type 17.14.2.2. By Product 17.14.2.3. By Disease 17.14.2.4. By Distribution Channel 17.15. India 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Species Type 17.15.2.2. By Product 17.15.2.3. By Disease 17.15.2.4. By Distribution Channel 17.16. ASEAN 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Species Type 17.16.2.2. By Product 17.16.2.3. By Disease 17.16.2.4. By Distribution Channel 17.17. Australia & New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Species Type 17.17.2.2. By Product 17.17.2.3. By Disease 17.17.2.4. By Distribution Channel 17.18. Japan 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Species Type 17.18.2.2. By Product 17.18.2.3. By Disease 17.18.2.4. By Distribution Channel 17.19. GCC countries 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Species Type 17.19.2.2. By Product 17.19.2.3. By Disease 17.19.2.4. By Distribution Channel 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Species Type 17.20.2.2. By Product 17.20.2.3. By Disease 17.20.2.4. By Distribution Channel 17.21. Israel 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Species Type 17.21.2.2. By Product 17.21.2.3. By Disease 17.21.2.4. By Distribution Channel 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Species Type 18.3.3. By Product 18.3.4. By Disease 18.3.5. By Distribution Channel 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Boehringer Ingelheim GmbH 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Zoetis Inc. 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Elanco Animal Health 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Merck & Co., Inc. 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Bayer AG 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Virbac Group 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Ceva Santé Animale 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Phibro Animal Health Corporation 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Elanco 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. HIPRA 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ million) Forecast by Region, 2017 to 2033 Table 2: Global Market Value (US$ million) Forecast by Species Type, 2017 to 2033 Table 3: Global Market Value (US$ million) Forecast by Product, 2017 to 2033 Table 4: Global Market Value (US$ million) Forecast by Disease, 2017 to 2033 Table 5: Global Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033 Table 6: North America Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 7: North America Market Value (US$ million) Forecast by Species Type, 2017 to 2033 Table 8: North America Market Value (US$ million) Forecast by Product, 2017 to 2033 Table 9: North America Market Value (US$ million) Forecast by Disease, 2017 to 2033 Table 10: North America Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033 Table 11: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 12: Latin America Market Value (US$ million) Forecast by Species Type, 2017 to 2033 Table 13: Latin America Market Value (US$ million) Forecast by Product, 2017 to 2033 Table 14: Latin America Market Value (US$ million) Forecast by Disease, 2017 to 2033 Table 15: Latin America Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033 Table 16: Western Europe Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 17: Western Europe Market Value (US$ million) Forecast by Species Type, 2017 to 2033 Table 18: Western Europe Market Value (US$ million) Forecast by Product, 2017 to 2033 Table 19: Western Europe Market Value (US$ million) Forecast by Disease, 2017 to 2033 Table 20: Western Europe Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033 Table 21: Eastern Europe Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 22: Eastern Europe Market Value (US$ million) Forecast by Species Type, 2017 to 2033 Table 23: Eastern Europe Market Value (US$ million) Forecast by Product, 2017 to 2033 Table 24: Eastern Europe Market Value (US$ million) Forecast by Disease, 2017 to 2033 Table 25: Eastern Europe Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033 Table 26: APEJ Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 27: APEJ Market Value (US$ million) Forecast by Species Type, 2017 to 2033 Table 28: APEJ Market Value (US$ million) Forecast by Product, 2017 to 2033 Table 29: APEJ Market Value (US$ million) Forecast by Disease, 2017 to 2033 Table 30: APEJ Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033 Table 31: Japan Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 32: Japan Market Value (US$ million) Forecast by Species Type, 2017 to 2033 Table 33: Japan Market Value (US$ million) Forecast by Product, 2017 to 2033 Table 34: Japan Market Value (US$ million) Forecast by Disease, 2017 to 2033 Table 35: Japan Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033 Table 36: MEA Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 37: MEA Market Value (US$ million) Forecast by Species Type, 2017 to 2033 Table 38: MEA Market Value (US$ million) Forecast by Product, 2017 to 2033 Table 39: MEA Market Value (US$ million) Forecast by Disease, 2017 to 2033 Table 40: MEA Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Figure 1: Global Market Value (US$ million) by Species Type, 2023 to 2033 Figure 2: Global Market Value (US$ million) by Product, 2023 to 2033 Figure 3: Global Market Value (US$ million) by Disease, 2023 to 2033 Figure 4: Global Market Value (US$ million) by Distribution Channel, 2023 to 2033 Figure 5: Global Market Value (US$ million) by Region, 2023 to 2033 Figure 6: Global Market Value (US$ million) Analysis by Region, 2017 to 2033 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 9: Global Market Value (US$ million) Analysis by Species Type, 2017 to 2033 Figure 10: Global Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033 Figure 11: Global Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033 Figure 12: Global Market Value (US$ million) Analysis by Product, 2017 to 2033 Figure 13: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 14: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 15: Global Market Value (US$ million) Analysis by Disease, 2017 to 2033 Figure 16: Global Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 17: Global Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 18: Global Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033 Figure 19: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 20: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 21: Global Market Attractiveness by Species Type, 2023 to 2033 Figure 22: Global Market Attractiveness by Product, 2023 to 2033 Figure 23: Global Market Attractiveness by Disease, 2023 to 2033 Figure 24: Global Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 25: Global Market Attractiveness by Region, 2023 to 2033 Figure 26: North America Market Value (US$ million) by Species Type, 2023 to 2033 Figure 27: North America Market Value (US$ million) by Product, 2023 to 2033 Figure 28: North America Market Value (US$ million) by Disease, 2023 to 2033 Figure 29: North America Market Value (US$ million) by Distribution Channel, 2023 to 2033 Figure 30: North America Market Value (US$ million) by Country, 2023 to 2033 Figure 31: North America Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 34: North America Market Value (US$ million) Analysis by Species Type, 2017 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033 Figure 37: North America Market Value (US$ million) Analysis by Product, 2017 to 2033 Figure 38: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 39: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 40: North America Market Value (US$ million) Analysis by Disease, 2017 to 2033 Figure 41: North America Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 42: North America Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 43: North America Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033 Figure 44: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 45: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 46: North America Market Attractiveness by Species Type, 2023 to 2033 Figure 47: North America Market Attractiveness by Product, 2023 to 2033 Figure 48: North America Market Attractiveness by Disease, 2023 to 2033 Figure 49: North America Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 50: North America Market Attractiveness by Country, 2023 to 2033 Figure 51: Latin America Market Value (US$ million) by Species Type, 2023 to 2033 Figure 52: Latin America Market Value (US$ million) by Product, 2023 to 2033 Figure 53: Latin America Market Value (US$ million) by Disease, 2023 to 2033 Figure 54: Latin America Market Value (US$ million) by Distribution Channel, 2023 to 2033 Figure 55: Latin America Market Value (US$ million) by Country, 2023 to 2033 Figure 56: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 59: Latin America Market Value (US$ million) Analysis by Species Type, 2017 to 2033 Figure 60: Latin America Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033 Figure 62: Latin America Market Value (US$ million) Analysis by Product, 2017 to 2033 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 65: Latin America Market Value (US$ million) Analysis by Disease, 2017 to 2033 Figure 66: Latin America Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 68: Latin America Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033 Figure 69: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 71: Latin America Market Attractiveness by Species Type, 2023 to 2033 Figure 72: Latin America Market Attractiveness by Product, 2023 to 2033 Figure 73: Latin America Market Attractiveness by Disease, 2023 to 2033 Figure 74: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 76: Western Europe Market Value (US$ million) by Species Type, 2023 to 2033 Figure 77: Western Europe Market Value (US$ million) by Product, 2023 to 2033 Figure 78: Western Europe Market Value (US$ million) by Disease, 2023 to 2033 Figure 79: Western Europe Market Value (US$ million) by Distribution Channel, 2023 to 2033 Figure 80: Western Europe Market Value (US$ million) by Country, 2023 to 2033 Figure 81: Western Europe Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 82: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 83: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 84: Western Europe Market Value (US$ million) Analysis by Species Type, 2017 to 2033 Figure 85: Western Europe Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033 Figure 86: Western Europe Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033 Figure 87: Western Europe Market Value (US$ million) Analysis by Product, 2017 to 2033 Figure 88: Western Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 89: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 90: Western Europe Market Value (US$ million) Analysis by Disease, 2017 to 2033 Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 93: Western Europe Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033 Figure 94: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 95: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 96: Western Europe Market Attractiveness by Species Type, 2023 to 2033 Figure 97: Western Europe Market Attractiveness by Product, 2023 to 2033 Figure 98: Western Europe Market Attractiveness by Disease, 2023 to 2033 Figure 99: Western Europe Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 100: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 101: Eastern Europe Market Value (US$ million) by Species Type, 2023 to 2033 Figure 102: Eastern Europe Market Value (US$ million) by Product, 2023 to 2033 Figure 103: Eastern Europe Market Value (US$ million) by Disease, 2023 to 2033 Figure 104: Eastern Europe Market Value (US$ million) by Distribution Channel, 2023 to 2033 Figure 105: Eastern Europe Market Value (US$ million) by Country, 2023 to 2033 Figure 106: Eastern Europe Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 109: Eastern Europe Market Value (US$ million) Analysis by Species Type, 2017 to 2033 Figure 110: Eastern Europe Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033 Figure 111: Eastern Europe Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033 Figure 112: Eastern Europe Market Value (US$ million) Analysis by Product, 2017 to 2033 Figure 113: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 114: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 115: Eastern Europe Market Value (US$ million) Analysis by Disease, 2017 to 2033 Figure 116: Eastern Europe Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 117: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 118: Eastern Europe Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033 Figure 119: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 120: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 121: Eastern Europe Market Attractiveness by Species Type, 2023 to 2033 Figure 122: Eastern Europe Market Attractiveness by Product, 2023 to 2033 Figure 123: Eastern Europe Market Attractiveness by Disease, 2023 to 2033 Figure 124: Eastern Europe Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 125: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 126: APEJ Market Value (US$ million) by Species Type, 2023 to 2033 Figure 127: APEJ Market Value (US$ million) by Product, 2023 to 2033 Figure 128: APEJ Market Value (US$ million) by Disease, 2023 to 2033 Figure 129: APEJ Market Value (US$ million) by Distribution Channel, 2023 to 2033 Figure 130: APEJ Market Value (US$ million) by Country, 2023 to 2033 Figure 131: APEJ Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 132: APEJ Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 133: APEJ Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 134: APEJ Market Value (US$ million) Analysis by Species Type, 2017 to 2033 Figure 135: APEJ Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033 Figure 136: APEJ Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033 Figure 137: APEJ Market Value (US$ million) Analysis by Product, 2017 to 2033 Figure 138: APEJ Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 139: APEJ Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 140: APEJ Market Value (US$ million) Analysis by Disease, 2017 to 2033 Figure 141: APEJ Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 142: APEJ Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 143: APEJ Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033 Figure 144: APEJ Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 145: APEJ Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 146: APEJ Market Attractiveness by Species Type, 2023 to 2033 Figure 147: APEJ Market Attractiveness by Product, 2023 to 2033 Figure 148: APEJ Market Attractiveness by Disease, 2023 to 2033 Figure 149: APEJ Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 150: APEJ Market Attractiveness by Country, 2023 to 2033 Figure 151: Japan Market Value (US$ million) by Species Type, 2023 to 2033 Figure 152: Japan Market Value (US$ million) by Product, 2023 to 2033 Figure 153: Japan Market Value (US$ million) by Disease, 2023 to 2033 Figure 154: Japan Market Value (US$ million) by Distribution Channel, 2023 to 2033 Figure 155: Japan Market Value (US$ million) by Country, 2023 to 2033 Figure 156: Japan Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 157: Japan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 158: Japan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 159: Japan Market Value (US$ million) Analysis by Species Type, 2017 to 2033 Figure 160: Japan Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033 Figure 161: Japan Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033 Figure 162: Japan Market Value (US$ million) Analysis by Product, 2017 to 2033 Figure 163: Japan Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 164: Japan Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 165: Japan Market Value (US$ million) Analysis by Disease, 2017 to 2033 Figure 166: Japan Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 167: Japan Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 168: Japan Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033 Figure 169: Japan Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 170: Japan Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 171: Japan Market Attractiveness by Species Type, 2023 to 2033 Figure 172: Japan Market Attractiveness by Product, 2023 to 2033 Figure 173: Japan Market Attractiveness by Disease, 2023 to 2033 Figure 174: Japan Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 175: Japan Market Attractiveness by Country, 2023 to 2033 Figure 176: MEA Market Value (US$ million) by Species Type, 2023 to 2033 Figure 177: MEA Market Value (US$ million) by Product, 2023 to 2033 Figure 178: MEA Market Value (US$ million) by Disease, 2023 to 2033 Figure 179: MEA Market Value (US$ million) by Distribution Channel, 2023 to 2033 Figure 180: MEA Market Value (US$ million) by Country, 2023 to 2033 Figure 181: MEA Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 184: MEA Market Value (US$ million) Analysis by Species Type, 2017 to 2033 Figure 185: MEA Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033 Figure 186: MEA Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033 Figure 187: MEA Market Value (US$ million) Analysis by Product, 2017 to 2033 Figure 188: MEA Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 189: MEA Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 190: MEA Market Value (US$ million) Analysis by Disease, 2017 to 2033 Figure 191: MEA Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 192: MEA Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 193: MEA Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033 Figure 194: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 195: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 196: MEA Market Attractiveness by Species Type, 2023 to 2033 Figure 197: MEA Market Attractiveness by Product, 2023 to 2033 Figure 198: MEA Market Attractiveness by Disease, 2023 to 2033 Figure 199: MEA Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 200: MEA Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports